biota pharmaceuticals inc
(BOTA:Consolidated Issue Listed on NASDAQ Global Select )
Douglas D. Richman M.D.
Member of Scientific Advisory Board, Biota Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 99 board members in 8 different organizations across 12 different industries.|
See Board Relationships
Dr. Douglas D. Richman, MD, is Professor of Pathology and Medicine at the University of California, San Diego School of Medicine and Chief of the Virology Section, Professor and Director of the Research Center for AIDS and HIV Infection at the San Diego VA Medical Center. Dr. Richman has investigated HIV disease and pathogenesis for the past 20 years and was the first to identify HIV drug resistance. He is also a virologist and practicing physician with the Veterans ...
2500 Northwinds ParkwayPhone: 678-221-3343
Alpharetta, Georgia 30009
Board Members Memberships*There is no Board Members Memberships data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Andrew Philip Witty||Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee|
|Paul Chaplin MSc, Ph.D.||Chief Executive Officer and President|
Bavarian Nordic A/S
|Anthony S. Marucci M.B.A.||Chief Executive Officer, President and Director|
Celldex Therapeutics, Inc.
|Peter Mørch Eriksen BBA||Chief Executive Officer and Administration Director|
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|$1.2M||Compensation as of Fiscal Year 2014.|